Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Microbiome therapy shows promise for preventing deadly bloodstream infections in early trial
United Kingdom
-
She Kept His Coat for 30 Years, Then Finally Found the Boy Who Gave It to Her After Racial Attack
United Kingdom
-
Single iron infusion improved exercise capacity in people with the most common form of heart failure
United Kingdom
-
Lucky Bird Found in Storm Drain a Mile From Home After Passing Driver Happens to Spot it Hopping in
United Kingdom
-
A 24-hour fast triggers a surprising repair response in the gut
United States
-
MIT scientists turn immune cells into cancer killers inside the body
United States
-
Climate change and funding cuts threaten malaria targets: what SADC countries can do
Australia
-
Good News in History, November 8
United Kingdom